Samaras et al. performed a comparative immunohistochemical analysis of Aurora-A and Aurora-B expression in 40 patients with primary glioblastomas to identify possible correlations with Ki-67 proliferation index and clinical outcomes (70). The gene discussed is MKI67; the disease is glioblastoma.